Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 10 [cited 2025 Jun. 20];2(13). Available from: https://journals.pagepress.org/hmr/article/view/485